Anthropic launches Claude Science to automate research like Claude Code does coding
Anthropic's new AI handles computational biology and drug development autonomously.
Anthropic unveiled Claude Science at an event for pharmaceutical executives, biotech founders, and researchers. The product is designed to autonomously carry out meaningful scientific work from concise, high-level instructions, mirroring the capabilities of Claude Code in software engineering. Claude Science comes with specialized tools for computational biology and drug development, enabling researchers to accelerate their workflows. The launch signals Anthropic's commitment to AI for science; the company will also deploy the product in its own research into drugs for rare, neglected diseases.
This move positions Anthropic as a key player in applying advanced AI to scientific discovery. By offering a dedicated product that can handle complex research tasks autonomously, the company aims to reduce the time and cost of drug development and biological analysis. The announcement comes alongside news that the US lifted restrictions on Anthropic's Mythos and Fable models, further expanding the company's reach in the AI landscape.
- Claude Science can autonomously execute high-level instructions for computational biology and drug development.
- Anthropic will use the product internally to research drugs for rare, neglected diseases.
- The launch mirrors the approach of Claude Code, but tailored for scientific research workflows.
Why It Matters
AI autonomy in scientific research could drastically accelerate drug discovery and reduce development costs for rare diseases.